Literature DB >> 15054402

Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.

Anne Fogli1, Raphael Schiffmann, Lynne Hugendubler, Patricia Combes, Enrico Bertini, Diana Rodriguez, Scot R Kimball, Odile Boespflug-Tanguy.   

Abstract

Mutations in each of the five eucaryotic initiation factor 2B (eIF2B) subunits have been found in leukodystrophies of various severity: Cree leukoencephalopathy, childhood ataxia with central hypomyelination/leukodystrophy with vanishing white matter and ovarioleukodystrophy. A continuum was observed from fatal infantile forms to adult forms without neurological deterioration. Disease severity was found to correlate with the age at disease onset and the specific amino-acid substitution. In order to analyze the functional consequences of eIF2B mutations, we measured the guanine nucleotide exchange factor (GEF) activity of eIF2B in transformed lymphocytes from 30 affected patients carrying mutations in eIF2B compared to 10 unaffected heterozygotes and 22 controls without eIF2B mutations. A significant decrease of 20-70% in GEF activity was observed in all mutated cells. The severity of this decrement of GEF activity correlated with age at onset of the disease. These results suggest that a deficiency in GEF activity underlies the encephalopathy associated eIF2B-related disease. Our study demonstrates that the evaluation of the GEF activity in transformed lymphocytes represents an interesting alternative test to the systematic screening of the five EIF2B genes. This relevant cellular model may also be used to test the functional impact of different molecules on the GEF activity for future therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054402     DOI: 10.1038/sj.ejhg.5201189

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  32 in total

1.  Clinical and neuroimaging findings of Cree leukodystrophy: a retrospective case series.

Authors:  S Harder; A Gourgaris; E Frangou; K Hopp; R Huntsman; N Lowry; S Seshia; E Lemire; C Robinson; J Tynan
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

2.  Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.

Authors:  Liraz Kantor; Heather P Harding; David Ron; Raphael Schiffmann; Christine R Kaneski; Scot R Kimball; Orna Elroy-Stein
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

3.  Regulation of the unfolded protein response by eif2Bdelta isoforms.

Authors:  Leenus Martin; Scot R Kimball; Lawrence B Gardner
Journal:  J Biol Chem       Date:  2010-08-13       Impact factor: 5.157

4.  Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships.

Authors:  Stephen T Turner; Myriam Fornage; Clifford R Jack; Thomas H Mosley; David S Knopman; Sharon L R Kardia; Eric Boerwinkle; Mariza de Andrade
Journal:  Arch Neurol       Date:  2009-07

5.  Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.

Authors:  Laetitia Horzinski; Liraz Kantor; Aurélia Huyghe; Raphael Schiffmann; Orna Elroy-Stein; Odile Boespflug-Tanguy; Anne Fogli
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

6.  Astrocytes are central in the pathomechanisms of vanishing white matter.

Authors:  Stephanie Dooves; Marianna Bugiani; Nienke L Postma; Emiel Polder; Niels Land; Stephen T Horan; Anne-Lieke F van Deijk; Aleid van de Kreeke; Gerbren Jacobs; Caroline Vuong; Jan Klooster; Maarten Kamermans; Joke Wortel; Maarten Loos; Lisanne E Wisse; Gert C Scheper; Truus E M Abbink; Vivi M Heine; Marjo S van der Knaap
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

Review 7.  Genes involved in leukodystrophies: a glance at glial functions.

Authors:  Odile Boespflug-Tanguy; Pierre Labauge; Anne Fogli; Catherine Vaurs-Barriere
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

8.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

Review 9.  Myelin under stress.

Authors:  Maurizio D'Antonio; M Laura Feltri; Lawrence Wrabetz
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

10.  Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.

Authors:  Laetitia Horzinski; Aurélia Huyghe; Marie-Céleste Cardoso; Céline Gonthier; Lemlih Ouchchane; Raphael Schiffmann; Pierre Blanc; Odile Boespflug-Tanguy; Anne Fogli
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.